|
1
|
Qiu X, Zhu X, Zhang L, Mao Y, Zhang J, Hao
P, Li G, Lv P, Li Z, Sun X, et al: Human epithelial cancers secrete
immunoglobulin g with unidentified specificity to promote growth
and survival of tumor cells. Cancer Res. 63:6488–6495.
2003.PubMed/NCBI
|
|
2
|
Li M, Feng DY, Ren W, Zheng L, Zheng H,
Tang M and Cao Y: Expression of immunoglobulin kappa light chain
constant region in abnormal human cervical epithelial cells. Int J
Biochem Cell Biol. 36:2250–2257. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Chen Z, Huang X, Ye J, Pan P, Cao Q, Yang
B, Li Z, Su M, Huang C and Gu J: Immunoglobulin G is present in a
wide variety of soft tissue tumors and correlates well with
proliferation markers and tumor grades. Cancer. 116:1953–1963.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Lee G, Laflamme E, Chien CH and Ting HH:
Molecular identity of a pan cancer marker, CA215. Cancer Biol Ther.
7:2007–2014. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Lee G: Cancer cell-expressed
immunoglobulins: CA215 as a pan cancer marker and its diagnostic
applications. Cancer Biomark. 5:137–142. 2009.PubMed/NCBI
|
|
6
|
Lee G and Ge BX: Cancer cell expressions
of immunoglobulin heavy chains with unique carbohydrate-associated
biomarker. Cancer Biomark. 5:177–188. 2009.PubMed/NCBI
|
|
7
|
Lee G, Ge B, Huang TK, Zheng G, Duan J and
Wang IH: Positive identification of CA215 pan cancer biomarker from
serum specimens of cancer patients. Cancer Biomark. 6:111–117.
2010.PubMed/NCBI
|
|
8
|
Lee G, Zhu M, Ge B and Potzold S:
Widespread expressions of immunoglobulin superfamily proteins in
cancer cells. Cancer Immunol Immunother. 61:89–99. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Lee G, Cheung AP, Li B, Ge B and Chow PM:
Molecular and immuno-characteristics of immunoglobulin-like
glycoproteins in cancer cell-expressed biomarker, CA215. Immunol
Invest. 41:429–446. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Lee G and Ge B: Inhibition of in vitro
tumor cell growth by RP215 monoclonal antibody and antibodies
raised against its anti-idiotype antibodies. Cancer Immunol
Immunother. 59:1347–1356. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Lee G, Chu RA and Ting HH: Preclinical
assessment of anti-cancer drugs by using RP215 monoclonal antibody.
Cancer Biol Ther. 8:161–166. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Tang L, Zhu P, Luo C, Xu XM and Fu N:
Preparation and identification of monoclonal antibodies against
different epitopes on human zeta globin chain. Di Yi Jun Yi Da Xue
Xue Bao. 25:1394–1397. 2005.(In Chinese). PubMed/NCBI
|
|
13
|
Xiao H, Zhu P, Liu B, Pan Q, Jiang X, Xu X
and Fu N: Generation and characterization of human
delta-globin-specific monoclonal antibodies. Blood Cells Mol Dis.
44:127–132. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Chen Y, Liu B, Yang D, Li X, Wen L, Zhu P
and Fu N: Peptide mimics of peptidoglycan are vaccine candidates
and protect mice from infection with Staphylococcus aureus. J Med
Microbiol. 60:995–1002. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Hou XR, Liu BY, Tian JW, Chen YG and Fu N:
Screening and Characterization of the Mimotopes of Adveanced
Oxidation Protein Products from Phage Peptide Library. Chinese
Journal of Laboratory Diagnosis. 15:765–768. 2011.
|
|
16
|
Nagy G and Pál T: Lipopolysaccharide: A
tool and target in enterobacterial vaccine development. Biol Chem.
389:513–520. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Samuel J, Noujaim AA, MacLean GD, Suresh
MR and Longenecker BM: Analysis of human tumor associated
Thomsen-Friedenreich antigen. Cancer Res. 50:4801–4808.
1990.PubMed/NCBI
|
|
18
|
Monzavi-Karbassi B, Luo P, Jousheghany F,
Torres-Quiñones M, Cunto-Amesty G, Artaud C and Kieber-Emmons T: A
mimic of tumor rejection antigen-associated carbohydrates mediates
an antitumor cellular response. Cancer Res. 64:2162–2166. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Tiwari R, Negi SS, Braun B, Braun W, Pomés
A, Chapman MD, Goldblum RM and Midoro-Horiuti T: Validation of a
phage display and computational algorithm by mapping a
conformational epitope of Bla g 2. Int Arch Allergy Immunol.
157:323–330. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Gazarian KG, Palacios-Rodriguez Y,
Gazarian TG and Huerta L: HIV-1 V3 loop crown epitope-focused
mimotope selection by patient serum from random phage display
libraries: Implications for the epitope structural features. Mol
Immunol. 54:148–156. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Hossany RB, Johnson MA, Eniade AA and
Pinto BM: Synthesis and immunochemical characterization of protein
conjugates of carbohydrate and carbohydrate-mimetic peptides as
experimental vaccines. Bioorgan Med Chem. 12:3743–3754. 2004.
View Article : Google Scholar
|
|
22
|
Lee G and Azadi P: Peptide mapping and
glycoanalysis of cancer cell-expressed glycoproteins CA215
recognized by RP215 monoclonal antibody. J Carbohyd Chem. 31:10–30.
2012. View Article : Google Scholar
|
|
23
|
Wu YZ, Zhang JB, Chen SY, Chen A, Wang L,
Li J, Zhao T, Zou L, Tang Y, Tingrong L and Wang F: Frequencies of
epitope-specific cytotoxic T lymphocytes in active chronic viral
hepatitis B infection by using MHC class I peptide tetramers.
Immunol Lett. 92:253–258. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Yamada A, Sasada T, Noguchi M and Itoh K:
Next-generation peptide vaccines for advanced cancer. Cancer Sci.
104:15–21. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Cheng WK, Wee K, Kollmann TR and Dutz JP:
Topical CpG adjuvantation of a protein-based vaccine induces
protective immunity to Listeria monocytogenes. Clin Vaccine
Immunol. 21:329–339. 2014. View Article : Google Scholar : PubMed/NCBI
|
